Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
European Journal of Clinical Pharmacology|January 1, 1996
Influence of repeated oral doses of ethinyloestradiol on the metabolic disposition of [13C2]-ethinyloestradiol in young womenW Kuhnz, M Hümpel, H Biere, et al.European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1994
Metabolism of the steroidal aromatase inhibitor atamestane in rats, cynomolgus monkeys and humans. Isolation and identification of the major metabolitesW Kuhnz, G A Hoyer, S Backhus, et al.Arzneimittel-Forschung|September 1, 1992
Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulationsW Kuhnz, B Schütt, J Power, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1991
Identification of the major metabolites of the prostaglandin E2-analogue sulprostone in human plasma, and isolation from urine (in vivo) and liver perfusate (in vitro) of female guinea-pigsW Kuhnz, G A Hoyer, S Backhus, et al.Arzneimittel-Forschung|January 1, 1993
Radioimmunological analysis of ethinylestradiol in human serum. Validation of the method and comparison with a gas chromatographic/mass spectrometric assayW Kuhnz, T Louton, D J Back, et al.Contraception|February 1, 1995
Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptorW Kuhnz, K H Fritzemeier, C Hegele-Hartung, et al.Contraception|March 12, 1998
In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal womenW Kuhnz, A Heuner, M Hümpel, et al.Arzneimittel-Forschung|April 1, 1996
Radioimmunological analysis of cyproterone acetate in human serum. Comparison with a gas chromatographic/mass spectrometric method and influence of each method on the outcome of a bioequivalence trialA Baumann, H Kulmann, V Gorkov, et al.The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 31, 2002
A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrelJ Endrikat, H Blode, C Gerlinger, et al.Clinical Pharmacokinetics|November 1, 1982
Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokineticsH Nau, W Kuhnz, H J Egger, et al.Pageof 7